Company Analysis Futura Medical plc
1. Summary
Advantages
- Price (0.01 $) is less than fair price (0.0944 $)
- The company's current efficiency (ROE=17.91%) is higher than the sector average (ROE=14.51%)
Disadvantages
- Dividends (0%) are below the sector average (1.7%).
- The stock's return over the last year (-93.33%) is lower than the sector average (-34.34%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Futura Medical plc | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -38.9% | -1.2% |
| 90 days | -80% | -36.4% | 1.9% |
| 1 year | -93.3% | -34.3% | 16.4% |
FAMDF vs Sector: Futura Medical plc has significantly underperformed the "Healthcare" sector by -58.99% over the past year.
FAMDF vs Market: Futura Medical plc has significantly underperformed the market by -109.72% over the past year.
Slightly volatile price: FAMDF is more volatile than the rest of the market on "OTC" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: FAMDF with weekly volatility of -1.79% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (0.01 $) is lower than the fair price (0.0944 $).
Price significantly below the fair price: The current price (0.01 $) is 844% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (72.98) is higher than that of the sector as a whole (45.46).
P/E vs Market: The company's P/E (72.98) is higher than that of the market as a whole (45.77).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (10.53) is higher than that of the sector as a whole (5.31).
P/BV vs Market: The company's P/BV (10.53) is higher than that of the market as a whole (4.38).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (6.78) is higher than that of the sector as a whole (4.3).
P/S vs Market: The company's P/S indicator (6.78) is lower than that of the market as a whole (12.38).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (64.27) is higher than that of the sector as a whole (17.43).
EV/Ebitda vs Market: The company's EV/Ebitda (64.27) is higher than that of the market as a whole (24.93).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -25.22% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-25.22%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-61.97%).
6.4. ROE
ROE vs Sector: The company's ROE (17.91%) is higher than that of the sector as a whole (14.51%).
ROE vs Market: The company's ROE (17.91%) is lower than that of the market as a whole (51.21%).
6.6. ROA
ROA vs Sector: The company's ROA (10.18%) is higher than that of the sector as a whole (7.45%).
ROA vs Market: The company's ROA (10.18%) is lower than that of the market as a whole (36.12%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.14%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.78%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.7%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
